New heart pill aims to strengthen weakened hearts
Disease control
Ongoing
This study is testing an investigational pill called JTT-861 for people with a specific type of chronic heart failure where the heart pumps less effectively. About 314 participants will take the pill or a placebo once daily for 12 weeks, in addition to their standard heart medica…
Phase: PHASE2 • Sponsor: Akros Pharma Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC